Data- driven precision medicine has been touted as the next frontier in oncology. Every day, millions of people across the globe are diagnosed with different types of cancer. The disease has become one of the biggest contributors to high mortality rates in the modern society. With more and more cases of cancer being reported, doctors are finding themselves in a situation where they need to comb through mountains of data for them to recommend the best therapies.
Eric Lefkosfky became aware of the challenges that oncologists faced in their work when he took his wife for treatment. A loved one to the businessman had been diagnosed with breast cancer, and she needed personalized therapies. It was at this moment that Eric discovered the limited amount of data that is available for oncologists to draw analyses and trends before they can recommend treatment. From this realization, Eric decided to come up with a technological solution that will avail genomic and therapeutic data from cancer patients so that doctors can draw patterns that will enable them to administer personalized cancer treatment solutions and learn more about Eric.
Tempus is a company that samples, collects and aggregates data from a cancer patient with the aim of drawing analytics that will help doctors in medical research to come up with more effective therapies for cancer. For a long time, personalized healthcare has been a preserve of the elite. Tempus is working to ensure that precision medicine can be made affordable to the average man. Unlike the existing cancer therapies that attack the cancer cells, Eric Lefkofsky’s company intends to come up with solutions that fight the disease at the molecular level.
Eric Lefkofsky was brought up in Southfield, Michigan. The entrepreneur graduated from the renowned University of Michigan. He earned his degree in laws from the Law School of the same institution. The business leader has also lived in Chicago for several years. He is best known in the corporate circles as the co-founder of Tempus and Groupon.
Apart from being committed to the advancement of research in medicine, Eric Lefkofsky is also involved in philanthropy. The seasoned entrepreneur has also been successful in the halls of academia. He currently holds the position of adjunct professor at the Business School of the University of Chicago and more information click here.